US Stock MarketDetailed Quotes

TTNPW TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayTrading Oct 9 16:00 ET
0Market Cap0.00P/E (TTM)

About TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B Company

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Company Profile

SymbolTTNPW
Company NameTITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B
CEOMr. Seow Gim Shen
MarketPink Market
Employees4
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Seow Gim Shen
  • Chairman of the Board, Chief Executive Officer and Principal Financial Officer
  • --
  • Dr. Marc Rubin,M.D.
  • Director
  • --
  • Brynner Chiam
  • Director
  • --
  • James R. Mcnab, Jr
  • Independent Director
  • --
  • Avraham Ben-Tzvi
  • Independent Director
  • --
  • Joseph A. Akers
  • Independent Director
  • --
  • Francisco Osvaldo Flores Garcia
  • Independent Director
  • --
  • Firdauz Edmin Bin Mokhtar
  • Independent Director
  • --
  • M. David MacFarlane, PhD
  • Independent Director
  • --

Trending Stocks

Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More